13 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and renal ... comparison between SGLT ... (Steglatro) #diabetes ... #SGLT2i #Inhibitors ... #pharmacology
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... Metformin + SGLT2 ... /ambcarerx #Diabetes ... Combination #Tablets #Oral ... #DM2 #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... of use) Common Side ... • Euglycemic diabetic ... #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... class of anti-diabetic ... #Inhibitors #Pharmacology ... Medications #DM2 #Diabetes
TACROLIMUS - Side Effects Mnemonic

Tremor 
Alopecia 
Cardiovascular (HTN) 
Renal insufficiency 
Oncologic (Skin Cancer) 
Lipids (hyperlipidemia) 
Insulin
TACROLIMUS - Side ... Cardiovascular (HTN) Renal ... Insulin dependent diabetes ... Seizures #Pharmacology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... in Diabetes Management ... Prandase) • SGLT ... @AmyChung #Oral ... #Management #pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... receptor agonist, SGLT2i ... insulin in Type 1 Diabetes ... insulin dose for renal ... #Medications #pharmacology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Most effective oral ... disease Common Side ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes
Metformin: Biguanide
Metformin is the first-line medication for treatment of type 2 diabetes. It is very effective
treatment of type 2 diabetes ... attention to patients renal ... is a potential side ... #Metformin #Pharmacology ... #Mechanism #Diabetes
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GI upset as a side ... minimize this side ... when compared to SGLT2 ... #semaglutide #Diabetes ... #Pharmacology #